Alert icon

To align with industry best practices for security and data integrity, Project Data Sphere is requiring users to upgrade their browsers to one that supports encryption protocol TLS 1.2 by December 15, 2017. On that date, Project Data Sphere will disable support of browsers that permit SSL 3.0/TLS 1.0. To prevent any disruption to your access to Project Data Sphere, you must take action.
This browser was not recognized and may not be compatible with TLS 1.2 or higher. Please check with the browser's developer to confirm.
To view information about this, please visit the FAQ. If you have any further questions, please contact us.

Back to the List
Type(s) of Cancer
Extensive Stage Small Cell Lung Carcinoma,Recurrent Small Cell Lung Carcinoma
Study Phase
Phase 2
Study Completion Date
November 2016
NCT00887159Uploaded 12-11-2020
Access via NCI by Request
PDS UID: nci-data-439
A Randomized Phase II Study of Cisplatin and Etoposide in Combination With Either Hedgehog Inhibitor GDC-0449 or IGF-1R MOAB IMC-A12 for Patients With Extensive Stage Small Cell Lung Cancer
Files: NCT00887159-D1
Data DictionaryNCT00887159-D1-Data-Dictionary_2.pdf
DATANCT00887159-D1-Dataset_1.csv
OTHERREADME.pdf
Files: NCT00887159-D2
Data DictionaryNCT00887159-D2-Data-Dictionary_3.pdf
DATANCT00887159-D2-Dataset_2.csv
OTHERREADME.pdf